流動負債 変化する 日付
AstraZeneca USD 31.27B 286M 2026-09
Genmab DKK 1.14B 38M 2026-06
GlaxoSmithKline GBP 20.72B 814M 2026-09
GRIFOLS EUR 2.3B 59M 2026-09
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lakefront Biotherapeutics EUR 48.33M 21.99M 2026-09
Qiagen NV USD 581.45M 102.34M 2026-06
UCB EUR 4.4B 470M 2025-12